Southpoint Capital Advisors’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
AI
CB
Southpoint Capital Advisors's XRAY Position: Q2 2026 in Review
Southpoint Capital Advisors reduced its Dentsply Sirona (XRAY) stake by 30% in Q2 2026, selling an estimated $32.8M and leaving 7,000,000 shares worth $74.3M. The position accounts for 1.69% of the portfolio, ranked #19.
Southpoint Capital Advisors first reported a position in XRAY in Q1 2026 and has held it in 2 quarters since. The position peaked at $116M in Q1 2026. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.
- Southpoint Capital Advisors held 7,000,000 shares of Dentsply Sirona worth $74.3M as of Q2 2026.
- Southpoint Capital Advisors sold 3,000,000 Dentsply Sirona shares in Q2 2026, an estimated $32.8M.
- Dentsply Sirona made up 1.69% of Southpoint Capital Advisors's portfolio in Q2 2026, its #19 holding.
- Southpoint Capital Advisors first reported a position in Dentsply Sirona in Q1 2026 and has held it in 2 quarters since.
- Southpoint Capital Advisors's Dentsply Sirona position peaked at $116M in Q1 2026.
- 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.
Based on Southpoint Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.